The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-3-(1-Acetyl-5-(1-methyl-1H-indol-5-yl)-4,5-dihydro-1H-pyrazol-3-yl)-6-chloro-4-phenylquinolin-2(1H)-one ID: ALA4535304
PubChem CID: 155547558
Max Phase: Preclinical
Molecular Formula: C29H23ClN4O2
Molecular Weight: 494.98
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N1N=C(c2c(-c3ccccc3)c3cc(Cl)ccc3[nH]c2=O)CC1c1ccc2c(ccn2C)c1
Standard InChI: InChI=1S/C29H23ClN4O2/c1-17(35)34-26(19-8-11-25-20(14-19)12-13-33(25)2)16-24(32-34)28-27(18-6-4-3-5-7-18)22-15-21(30)9-10-23(22)31-29(28)36/h3-15,26H,16H2,1-2H3,(H,31,36)
Standard InChI Key: OFBXPBNKCDEJSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
29.7324 -20.6289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7312 -21.4571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4432 -21.8683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4413 -20.2137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1580 -20.6253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1568 -21.4546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8710 -21.8659 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5910 -21.4566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5922 -20.6273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8734 -20.2073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8739 -19.3856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5913 -18.9754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5916 -18.1504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8754 -17.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1572 -18.1539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1604 -18.9776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3068 -20.2131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0608 -20.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6121 -19.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2029 -19.2230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3947 -19.3920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3056 -21.8695 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5389 -18.4689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3604 -18.3850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0575 -17.7990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4357 -19.9359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8510 -20.6502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6637 -19.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8422 -19.2232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0198 -20.2198 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
37.0812 -19.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6758 -20.6458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2310 -21.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9795 -20.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8868 -20.0949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.4929 -19.5402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
10 11 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 17 2 0
9 17 1 0
8 22 2 0
20 23 1 0
23 24 1 0
23 25 2 0
19 26 1 0
26 27 2 0
27 32 1 0
31 28 1 0
28 29 2 0
29 26 1 0
1 30 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 31 1 0
35 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 494.98Molecular Weight (Monoisotopic): 494.1510AlogP: 6.04#Rotatable Bonds: 3Polar Surface Area: 70.46Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.88CX Basic pKa: ┄CX LogP: 5.24CX LogD: 5.24Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.33Np Likeness Score: -0.90
References 1. Bagnolini G, Milano D, Manerba M, Schipani F, Ortega JA, Gioia D, Falchi F, Balboni A, Farabegoli F, De Franco F, Robertson J, Pellicciari R, Pallavicini I, Peri S, Minucci S, Girotto S, Di Stefano G, Roberti M, Cavalli A.. (2020) Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib., 63 (5): [PMID:32037829 ] [10.1021/acs.jmedchem.9b01526 ]